Elevated serum bone morphogenese protein 7 levels and clinical outcome in children with biliary atresia

European Journal of Pediatric Surgery

Volumn 19, Issue 4, 2009, Pages 246-250

  Chayanupatkul, M ^a   Honsawek, Sittisak ^a   Vejchaplpat, P ^a   Chongsrisawar, V ^a   Poovorawan, Y ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Biliary atresia; BMP7; Clinical outcome; Jaundice

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; OSTEOGENIC PROTEIN 1; BIOLOGICAL MARKER;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT ATRESIA; BILIRUBIN BLOOD LEVEL; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PORTOENTEROSTOMY; PROTEIN BLOOD LEVEL; SERUM; TREATMENT OUTCOME; BLOOD; COMPARATIVE STUDY; HOSPITALIZATION; PREDICTION AND FORECASTING;

BILIARY ATRESIA; BIOLOGICAL MARKERS; BONE MORPHOGENETIC PROTEIN 7; CHILD; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 73949110803     PISSN: 09397248     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1216378     Document Type: Article

References (24)

1. Á-Kader HH, Abdel-Hameed A, Al-Shabrawi M et al. Is biliary atresia an autoimmune disease? Eur J Gastroenterol Hepatol 2003; 15: 447
2. Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001; 21: 373-384
3. Davenport M. Biliary atresia. Semin Pediatr Surg 2005; 14: 42-48
4. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-1835
5. Gabele E, Brenner DA, Rippe RA. Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front Biosci 2003; 8: d69-d77
6. Gressner OA, Rizk MS, Kovalenko E et al. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go? J Gastroenterol Hepatol 2008; 23: 1024-1035
7. Honsawek S, Chongsrisawat V, Vejchapipat P et al. High levels of serum basic fibroblast growth factor in children with biliary atresia. Hepatogastroenterology 2008; 55: 1184-1188
8. Honsawek S, Chongsrisawat V, Vejchapipat P et al. Serum interleukin8 in children with biliary atresia: relationship with disease stage and biochemical parameters. Pediatr Surg Int 2005; 21: 73-77
9. Honsawek S, Chongsrisawat V, Vejchapipat P et al. Elevation of serum stem-cell factor in postoperative biliary atresia. Pediatr Int 2007; 49: 888-893
10. Houston B, Thorp BH, Burt DW. Molecular cloning and expression of bone morphogenetic protein-7 in the chick epiphyseal growth plate. J Mol Endocrinol 1994; 13: 289-301
11. Hruska KA, Guo G, Wozniak M et al. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol 2000; 279: F130-143
12. Iwano M, Plieth D, Danoff TM et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350
13. Karrer FM, Price MR, Bensard DD et al. Long-term results with the Kasai operation for biliary atresia. Arch Surg 1996; 131: 493-496
14. Kinoshita K, Iimuro Y, Otogawa K et al. Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats. Gut 2007; 56: 706-714
15. Kobayashi H, Stringer MD. Biliary atresia. Semin Neonatal 2003; 8: 383-391
16. Sugimoto H, Yang C, LeBleu VS et al. BMP-7 functions as a novel hormone to facilitate liver regeneration. FASEB J 2007; 21: 256-264
17. Tacke F, Gabele E, Bataille F et al. Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells. Dig Dis Sci 2007; 52: 3404-3415
18. Urushihara N, Iwagaki H, Yagi T et al. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. J Pediatr Surg 2000; 35: 446-449
19. Vejchapipat P, Theamboonlers A, Chaokhonchai R et al. Serum hepatocyte growth factor and clinical outcome in biliary atresia. J Pediatr Surg 2004; 39: 1045-1049
20. Vejchapipat P, Theamboonlers A, Poomsawat S et al. Serum transforming growth factor-betal and epidermal growth factor in biliary atresia. Eur J Pediatr Surg 2008; 18: 415-418
21. Weiskircfien R, Meurer SK. Bone morphogenetic protein-7 in focus: a member of the transforming growth factor-beta superfamily is implicated in the maintenance of liver health. Hepatology 2007; 45: 1324-1325
22. Zeisberg M, Hanoi J, Sugimoto H et al. BMP-7 counteracts TGF-betal-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 2003; 9: 964-968
23. Zeisberg M, Shah AA, Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem 2005; 280: 8094-8100
24. Zeisberg M, Yang C, Martino M et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007; 282:23337-23347